Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000909518-08-000331
Filing Date
2008-04-09
Accepted
2008-04-09 16:37:13
Documents
1
Period of Report
2008-04-07

Document Format Files

Seq Description Document Type Size
1 pfizer_form4ex.html 4  
1 pfizer_form4ex.xml 4 4711
  Complete submission text file 0000909518-08-000331.txt   6905
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Reporting) CIK: 0000078003 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-20117 | Film No.: 08747996
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081
Business Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081 7137968822
ENCYSIVE PHARMACEUTICALS INC (Issuer) CIK: 0000887023 (see all company filings)

EIN.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations